Towards omitting breast cancer surgery in select patient groups: Assessment of pathologic complete response after neoadjuvant systemic therapy using biopsies-The MICRA trial.

被引：2
|
作者：
Van Der Noordaa, Marieke
van Duijnhoven, Frederieke
Loo, Claudette
van der Vijver, Koen
Sonke, Gabe S.
Van Der Pol, Carmen
Francken, Anne Brecht
Peeters, Marie-Jeanne Vrancken
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.TPS593
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS593
引用
收藏
页数：6
相关论文
共 50 条
  • [1] owards omitting breast cancer surgery in patients with pathologic complete response after neoadjuvant systemic therapy: The MICRA trial (minimally invasive complete response assessment)
    van der Noordaa, M. E.
    van Duijnhoven, F. H.
    Loo, C. E.
    van Loevezijn, A.
    van Werkhoven, E.
    van de Vijver, K. K.
    Wiersma, T.
    Winter-Warnars, H. A.
    Sonke, G. S.
    Peeters, M-J T. Vrancken
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [2] Towards omitting breast surgery in patients with a pathologic complete response after neoadjuvant systemic treatment: interim analysis of the MICRA trial (Minimally Invasive Complete Response Assessment)
    Peeters, Marie-Jeanne T. F. D. Vrancken
    van Loevezijn, A.
    van der Noordaa, M. E. M.
    van Duijnhoven, F. H.
    Loo, C. E.
    van Werkhoven, E.
    van de Vijver, K. K.
    Wiersma, T.
    Winter-Warnars, H. A. O.
    Sonke, G. S.
    Blanken, C.
    Zonnevels, B.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [3] Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)
    van der Noordaa, M. E. M.
    van Duijnhoven, F. H.
    Loo, C. E.
    van Werkhoven, E.
    van de Vijver, K. K.
    Wiersma, T.
    Winter-Warnars, H. A. O.
    Sonke, G. S.
    Peeters, M. T. F. D. Vrancken
    [J]. BREAST, 2018, 40 : 76 - 81
  • [4] Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study
    Ariane A. van Loevezijn
    Marieke E.M. van der Noordaa
    Erik D. van Werkhoven
    Claudette E. Loo
    Gonneke A. O. Winter-Warnars
    Terry Wiersma
    Koen K. van de Vijver
    Emilie J. Groen
    Charlotte F. J. M. Blanken-Peeters
    Bas J.G.L. Zonneveld
    Gabe S. Sonke
    Frederieke H. van Duijnhoven
    Marie-Jeanne T. F. D. Vrancken Peeters
    [J]. Annals of Surgical Oncology, 2021, 28 : 3243 - 3253
  • [5] Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study
    van Loevezijn, Ariane A.
    van der Noordaa, Marieke E. M.
    van Werkhoven, Erik D.
    Loo, Claudette E.
    Winter-Warnars, Gonneke A. O.
    Wiersma, Terry
    van de Vijver, Koen K.
    Groen, Emilie J.
    Blanken-Peeters, Charlotte F. J. M.
    Zonneveld, Bas J. G. L.
    Sonke, Gabe S.
    van Duijnhoven, Frederieke H.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3243 - 3253
  • [6] Artificial intelligence to accurately identify and select breast cancer patients with a pathologic complete response for omission of surgery after neoadjuvant systemic therapy: an international multicenter analysis
    Pfob, A.
    Sidey-Gibbons, C.
    Tasoulis, M. K.
    Lee, H. B.
    Koelbel, V
    Kuerer, H. M.
    Heil, J.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E88 - E88
  • [7] Minimally Invasive Complete Response Assessment of the breast after neoadjuvant systemic therapy (MICRA trial): Interim analysis of a multicenter observational cohort study
    Van Loevezijn, A.
    van der Noordaa, M. E. M.
    van Werkhoven, E.
    Loo, C. E.
    Winter-Warnars, G. H. A. O.
    Wiersma, T.
    van de Vijver, K. K.
    Groen, E. J.
    Sonke, G. S.
    Blanken, C. F. J. M.
    Zonneveld, B.
    Duijnhoven, F. H.
    Vrancken-Peeters, M. J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S9 - S10
  • [8] Identifying determinants of pathologic complete response in patients with breast cancer after receiving neoadjuvant systemic therapy
    Chan, Abigail Sy
    Bhargava, Anika
    Chandler, Natasha
    Tavcar, Michelle
    Gunaratnam, Bakeerathan
    Dong, Brian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers
    Myers, Sara P.
    Sevilimedu, Varadan
    Barrio, Andrea V.
    Tadros, Audree B.
    Mamtani, Anita
    Robson, Mark E.
    Morrow, Monica
    Lee, Minna K.
    [J]. NPJ BREAST CANCER, 2024, 10 (01)
  • [10] Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings
    von Minckwitz, Gunter
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 779 - 780
12345